US Patent

US10414831 — Stable iron oligosaccharide compound

Composition of Matter · Assigned to Pharmacosmos Holding AS · Expires 2029-03-25 · 3y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects a stable iron oligosaccharide compound with improved stability, comprising a hydrogenated oligosaccharide and ferric oxyhydroxide.

USPTO Abstract

The invention relates to an iron oligosaccharide compound with improved stability comprising a hydrogenated oligosaccharide in stable association with ferric oxyhydroxide, the content of dimes saccharide in said hydrogenated oligosaccharide being 2.9% by weight or less, based on the total weight of the hydrogenated oligosaccharide. In further aspects is provided a process for preparing said compound as well as the use of said compound for preparation of a composition for treatment of iron deficiency anaemia.

Drugs covered by this patent

Patent Metadata

Patent number
US10414831
Jurisdiction
US
Classification
Composition of Matter
Expires
2029-03-25
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Pharmacosmos Holding AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.